Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: Results from a vaccine safety datalink study

American Journal of Public Health

Volumn 99, Issue SUPPL. 2, 2009, Pages

  Nelson, Jennifer C ^a,b,j   Bittner, Rachel C L ^a,b   Bounds, Lora ^a   Zhao, Shanshan ^a,b   Baggs, James ^c   Donahue, James G ^d   Hambidge, Simon J ^e   Jacobsen, Steven J ^f   Klein, Nicola P ^g   Naleway, Allison L ^h   Zangwill, Kenneth M ⁱ   Jackson, Lisa A ^a,b  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MARSHFIELD CLINIC   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f KAISER PERMANENTE   (United States)

^g DIVISION OF RESEARCH   (United States)

^h CENTER FOR HEALTH RESEARCH   (United States)

ⁱ LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^j NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG DOSE REGIMEN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MULTIPLE DRUG DOSE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; MALE; MEDICAID; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 70350067609     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.151332     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45(RR-11):1-36.
2. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45(RR-15):1-30.
3. Centers for Disease Control and Prevention. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep. 1982;31(24):317-322, 327-1318
4. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40(RR-13):1-25.
5. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24.
6. Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, Andre FE. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis. 1995;171(suppl 1):S44-S49.
7. McMahon BJ, Williams J, Bulkow L, et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J Infect Dis. 1995;171(3):676-679.
8. Ashur Y, Adler R, Rowe M, Shouval D. Comparison of immunogenicity of two hepatitis A vaccines - VAQTA and HAVRIX-in young adults. Vaccine. 1999;17(18):2290-2296. (Pubitemid 29225681)
9. Balcarek KB, Bagley MR, Pass RF, Schiff ER, Krause DS. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. J Infect Dis. 1995;171(suppl 1):S70-S72.
10. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J. 1993;12(5):359-362. (Pubitemid 23150795)
11. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers. J Gastroenterol Hepatol. 1993;8(4):338-341. (Pubitemid 23203399)
12. Coates T, Wilson R, Patrick G, Andre F, Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther. 2001;23(3):392-403. (Pubitemid 32328745)
13. Leroux-Roels G, Abraham B, Fourneau M, De Clercq N, Safary A. A comparison of two commercial recombinant vaccines for hepatitis B in adolescents. Vaccine. 2000;19(7-8):937-942.
14. Andre FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med. 1989;87(3A):14S-20S.
15. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect. 1986;13(suppl A):39-45.
16. Kuter BJ, Ngai A, Patterson A, et al. Safety, tolerability, immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group. Vaccine. 1995;13(11):967-972.
17. Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis. 1988;158(1):132-137. (Pubitemid 18189009)
18. Centers for Disease Control and Prevention. National Immunization Survey home page. Available at: http://www.cdc.gov/nis. Accessed May 1, 2008.
19. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(40):1100-1103.
20. Centers for Disease Control and Prevention. National Health Interview Survey home page. Available at: http://www.cdc.gov/nchs/nhis.htm. Accessed May 1, 2008.
21. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System home page. Available at: http://www.cdc.gov/brfss. Accessed May 1, 2008.
22. International Classification of Diseases, Ninth Revision, Clinical Modification. Hyattsville, MD: National Center for Health Statistics; 1980. DHHS publication PHS 80-1260.
23. DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10(5):403-406.
24. Lumley T, Kronmal RA, Ma S. Relative Risk Regression in Medical Research: Models, Contrasts, Estimators and Algorithms. Seattle: University of Washington; 2006. UW Biostatistics Working Paper Series, paper 293. Available at: http://www.bepress.com.offcampus.lib.washington.edu/uwbiostat/paper293. Accessed July 19, 2006.
25. Sansom S, Rudy E, Strine T, Douglas W. Hepatitis A and B vaccination in a sexually transmitted disease clinic for men who have sex with men. Sex Transm Dis. 2003;30(9):685-688. (Pubitemid 37087853)
26. Campbell JV, Garfein RS, Thiede H, et al. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend. 2007;91(suppl 1):S64-S72. (Pubitemid 47470019)
27. Macdonald V, Dore GJ, Amin J, van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health. 2007;4(1):27-30. (Pubitemid 46311098)
28. Owen EC, Peddecord KM, Wang WW, et al. Hepatitis A vaccine uptake in San Diego County: Hispanic children are better immunized. Arch Pediatr Adolesc Med. 2005;159(10):971-976.
29. Fiore A, Baxter LC, Bell BP, et al. Hepatitis A 2004 vaccination in children: methods and findings of a survey in two states. Am J Prev Med. 2007;33(4):346-352.
30. Bardenheier B, Gonzalez IM, Washington ML, et al. Parental knowledge, attitudes, and practices associated with not receiving hepatitis A vaccine in a demonstration project in Butte County, California. Pediatrics. 2003;112(4):e269.
31. Gonzalez IM, Averhoff FM, Massoudi MS, et al. Hepatitis B vaccination among adolescents in 3 large health maintenance organizations. Pediatrics. 2002;110(5):929-934.
32. Middleman AB, Robertson LM, Young C, Durant RH, Emans SJ. Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health. 1999;25(5):323-327. (Pubitemid 29495866)
33. Centers for Disease Control and Prevention. Hepatitis B vaccination coverage among adults-United States, 2004. MMWR Morb Mortal Wkly Rep. 2006;55(18):509-511.
34. Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007;161(3):252-259. (Pubitemid 46364328)
35. Humiston SG, Rosenthal SL. Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J. 2005;24(6 suppl):S134-S140.
36. Bloom HG, Wheeler DA, Linn J. A managed care organization's attempt to increase influenza and pneumococcal immunizations for older adults in an acute care setting. J Am Geriatr Soc. 1999;47(1):106-110. (Pubitemid 29044275)
37. Mullooly J, Drew L, DeStefano F, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team. Am J Epidemiol. 1999;149(2):186-194.